🚀 VC round data is live in beta, check it out!
Finemedix Valuation Multiples
Discover revenue and EBITDA valuation multiples for Finemedix and similar public comparables like Lifeward, aap Implantate, Modular Medical, Harvard Bioscience and more.
Finemedix Overview
About Finemedix
Finemedix Co Ltd is engaged in manufacturing of other medical and surgical equipment and orthopedic appliances. The company is engaged in production of endoscopic surgical instruments and domestically produced functionally endoscopic incisions, snares, etc. The company is supplying its products to several university hospitals, large hospitals, and clinics in Korea, and are continuously planning and developing products that actively reflect the ideas of developed domestic medical staff and voices from the field. In addition, the company is preparing for overseas exports by obtaining CE and FDA certifications and is emerging as a specialized medical device company.
Founded
2009
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$25M
Finemedix Financials
Finemedix reported last fiscal year revenue of $6M and negative EBITDA of ($1M).
In the same fiscal year, Finemedix generated $3M in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).
Finemedix P&L
In the most recent fiscal year, Finemedix reported revenue of $6M and EBITDA of ($1M).
Finemedix expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $6M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $3M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 48% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (16%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (27%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (20%) | XXX | XXX | XXX |
| Net Debt | — | — | $273K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Finemedix Stock Performance
Finemedix has current market cap of $26M, and enterprise value of $25M.
Market Cap Evolution
Finemedix's stock price is $4.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25M | $26M | 0.0% | XXX | XXX | XXX | $-0.24 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFinemedix Valuation Multiples
Finemedix trades at 3.8x EV/Revenue multiple, and (24.0x) EV/EBITDA.
Finemedix Financial Valuation Multiples
As of April 20, 2026, Finemedix has market cap of $26M and EV of $25M.
Equity research analysts estimate Finemedix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Finemedix has a P/E ratio of (20.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $26M | XXX | $26M | XXX | XXX | XXX |
| EV (current) | $25M | XXX | $25M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (24.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (13.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 7.8x | XXX | XXX | XXX |
| P/E | — | XXX | (20.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (10.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Finemedix Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Finemedix Margins & Growth Rates
Finemedix's revenue in the last fiscal year declined by (4%).
Finemedix Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (16%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (265%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Finemedix Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Finemedix | XXX | XXX | XXX | XXX | XXX | XXX |
| Lifeward | XXX | XXX | XXX | XXX | XXX | XXX |
| aap Implantate | XXX | XXX | XXX | XXX | XXX | XXX |
| Modular Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Harvard Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| CS Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Finemedix M&A Activity
Finemedix acquired XXX companies to date.
Last acquisition by Finemedix was on XXXXXXXX, XXXXX. Finemedix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Finemedix
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFinemedix Investment Activity
Finemedix invested in XXX companies to date.
Finemedix made its latest investment on XXXXXXXX, XXXXX. Finemedix invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Finemedix
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Finemedix
| When was Finemedix founded? | Finemedix was founded in 2009. |
| Where is Finemedix headquartered? | Finemedix is headquartered in South Korea. |
| Is Finemedix publicly listed? | Yes, Finemedix is a public company listed on Korea Exchange. |
| What is the stock symbol of Finemedix? | Finemedix trades under 387570 ticker. |
| When did Finemedix go public? | Finemedix went public in 2024. |
| Who are competitors of Finemedix? | Finemedix main competitors are Lifeward, aap Implantate, Modular Medical, Harvard Bioscience. |
| What is the current market cap of Finemedix? | Finemedix's current market cap is $26M. |
| What is the current revenue of Finemedix? | Finemedix's last fiscal year revenue is $6M. |
| What is the current EV/Revenue multiple of Finemedix? | Current revenue multiple of Finemedix is 3.8x. |
| Is Finemedix profitable? | No, Finemedix is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.